Harrow (HROW) Change in Accured Expenses (2010 - 2026)
Harrow (HROW) posted quarterly Change in Accured Expenses of $3.4 million for Q1 2026, up 278.58% year-over-year from $892011.0 in Q1 2025, and down 87.93% quarter-over-quarter from $28.0 million in Q4 2025.
Harrow (HROW) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Harrow's Change in Accured Expenses history runs 17 years deep, the most recent figure standing at $3.4 million for Q1 2026.
- In Q1 2026, Change in Accured Expenses rose 278.58% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $6.2 million (down 86.07% YoY), while the FY2025 annual figure was $936000.0, down 97.5% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $3.4 million, down from $28.0 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $35.8 million in Q4 2024, with the low at -$22.1 million in Q2 2025.
- The 5-year median for Change in Accured Expenses is -$598000.0 (2022), against an average of $2.6 million.
- Peak annual rise in Change in Accured Expenses reached 27200.0% in 2024, while the deepest fall reached 704.59% in 2024.
- Harrow's Change in Accured Expenses stood at -$598000.0 in 2022, then jumped by 121.91% to $131000.0 in 2023, then soared by 27200.0% to $35.8 million in 2024, then slipped by 21.75% to $28.0 million in 2025, then tumbled by 87.93% to $3.4 million in 2026.
- Business Quant data shows HROW's Change in Accured Expenses at $3.4 million in Q1 2026, $28.0 million in Q4 2025, and -$3.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 82.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 142.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -219.00 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -4.00 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -8.50 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Harrow | 1.53 Bn | 1.45 Bn | 50.36 Mn | 8.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.54 Mn |
| Jun 30, 2026 | 8.54 Mn |
| Mar 31, 2026 | 3.38 Mn |
| Mar 31, 2026 | 3.38 Mn |
| Dec 31, 2025 | 27.99 Mn |
| Dec 31, 2025 | 27.99 Mn |
| Sep 30, 2025 | -3.04 Mn |
| Sep 30, 2025 | -3.04 Mn |
| Jun 30, 2025 | -22.12 Mn |
| Jun 30, 2025 | -22.12 Mn |
| Mar 31, 2025 | -1.89 Mn |
| Mar 31, 2025 | -1.89 Mn |
| Dec 31, 2024 | 35.76 Mn |
| Dec 31, 2024 | 35.76 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Sep 30, 2024 | 1.46 Mn |
| Jun 30, 2024 | 9.21 Mn |
| Jun 30, 2024 | 9.21 Mn |
| Mar 31, 2024 | -8.94 Mn |
| Mar 31, 2024 | -8.94 Mn |